Brief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
23/09/2026 22:08
BRIEF-Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy Sept 24 (Reuters) - Evofem Biosciences Inc EVFM.PK:
EVOFEM BIOSCIENCES ADDS ADDITIONAL MANUFACTURING CAPACITY FOR PHEXX® TO SUPPORT GLOBAL GROWTH STRATEGY
EVOFEM BIOSCIENCES - TO SUBMIT SNDA TO FDA FOR PHEXX IN MID-2027
EVOFEM BIOSCIENCES - ADDITIONAL MANUFACTURING SOURCE EXPECTED TO REDUCE UNIT COSTS BY 40% OR MORE
Source text: ID:nBw1tpTGBa
Further company coverage: EVFM.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting